5-Formylcytosine (5fC) is a key intermediate in active DNA demethylation, offering a direct snapshot of ongoing epigenetic reprogramming. CD BioSciences provides highly sensitive and specific 5fC analysis services, empowering researchers to map this elusive modification and uncover its role in gene regulation, development, and disease etiology.
5-Formylcytosine (5fC) is an oxidative derivative of 5-methylcytosine (5mC), generated primarily by the Ten-Eleven Translocation (TET) family of enzymes during the iterative oxidation process of active DNA demethylation. As a rare and transient epigenetic mark, 5fC is present at low abundance in genomic DNA but is enriched at specific regulatory regions such as enhancers, promoters, and gene bodies of transcriptionally active genes.
Functionally, 5fC is more than just a demethylation intermediate. Emerging evidence suggests it may serve as a stable epigenetic signal in its own right, potentially recruiting specific reader proteins and influencing chromatin structure and transcription. Its unique chemical properties also distinguish it from 5mC and 5hmC. The biological significance of 5fC is profound: its dynamic regulation is crucial for embryonic development, cellular differentiation, and tissue homeostasis. Aberrant 5fC levels or distribution have been implicated in various cancers, neurological disorders, and other diseases, making it a valuable target for understanding epigenetic dysregulation and discovering novel biomarkers.

Fig.1 Active demethylation of 5mC by TET dioxygenases and local enrichment of 5fC. (Kumar D, et al., 2024)
CD BioSciences delivers cutting-edge, reliable 5fC analysis services designed to overcome the challenge of detecting this low-abundance modification. We leverage state-of-the-art chemical and sequencing technologies to provide precise, base-resolution mapping and quantitative analysis of 5fC. Our end-to-end solutions, from expert consultation to in-depth bioinformatic interpretation, empower you to elucidate the functional landscape of 5fC in your biological system, accelerating discoveries in developmental biology, neuroepigenetics, and oncology.
At CD BioSciences, we provide a comprehensive suite of advanced technologies to accurately detect and map 5-formylcytosine (5fC). Our platform integrates highly specific chemical-assisted bisulfite sequencing (e.g., fCAB-seq), selective chemical labeling and enrichment methods, and sensitive mass spectrometry-based quantification. This multi-technology approach enables precise, base-resolution 5fC profiling tailored to diverse sample types and research goals, ensuring you obtain reliable data even from low-abundance epigenetic marks.

Our 5fC analysis follows a meticulously designed technical pipeline focused on the precise handling of this low-abundance, labile modification. Each step is optimized to ensure maximum specificity, sensitivity, and data integrity, reflecting our deep expertise in advanced epigenomic profiling.

Beyond 5fC, CD BioSciences offers a complete portfolio of DNA modification analysis services. We provide tailored, end-to-end solutions for studying 5mC, 5hmC, 5caC, 6mA, 4mC, and 8-oxoG, among others. Our flexible and customizable workflows are designed to support your specific research focus, whether in demethylation pathways, epigenetic inheritance, or disease mechanism exploration. Contact us to build the precise epigenetic profiling strategy your project requires.
Reference 1. Kumar D, Hyder I, Kues W A. 5-Formylcytosine: a new epigenetic player[J]. Signal Transduction and Targeted Therapy, 2024, 9(1): 295.
USA
Quick Links
Easy access to products and services you need from our library via powerful searching tools
Privacy Policy | Cookie Policy
Copyright © 2026 CD BioSciences. All Rights Reserved.